Massachusetts Medical Society

SHERPA: Blue

People

  1. Zelenetz
    Zelenetz
  2. Palomba
    Palomba
  3. Abdel-Wahab
    Abdel-Wahab
  4. Argyropoulos
    Argyropoulos
  5. Chaganti
    Chaganti
  6. Durham
    Durham
  7. Geyer
    Geyer
  8. Hamlin
    Hamlin
  9. Jhanwar
    Jhanwar
  10. Ladanyi
    Ladanyi

Groups

  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Lymphoma (17)
  5. Executive Committee, Center for Hematologic Malignancies (2)
  6. GSK Faculty (2)
  7. Graduate Medical Education (2)
  8. Human Oncology and Pathogenesis Program (2)
  9. Sloan Kettering Institute Postdocs (2)
  10. Survivorship Research (2)
Search Within
  1. "Lymphoma"
Formats
  1. Journal Article (16)
  2. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Lymphoma (17)
  5. Executive Committee, Center for Hematologic Malignancies (2)
  6. GSK Faculty (2)

More Groups

People
  1. David Straus (6)
  2. Andrew Zelenetz (5)
  3. Maria Palomba (4)
  4. Carol Portlock (2)
  5. Alexander Penson (1)
  6. Anas Younes (1)

More People

Years
  1. 2022 (5)
  2. 2018 (4)
  3. 2015 (1)
  4. 2014 (1)
  5. 2012 (1)
  6. 1997 (2)

More Years

Publications
  1. New England Journal of Medicine (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin in advanced Hodgkin's lymphoma: The authors reply
    Correspondence

    Ansell, S. M.; Radford, J.; Straus, D. J.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Radford, J.; Connors, J. M.; Długosz-Danecka, M.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R.; Hutchings, M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma
    Journal Article

    Wang, M. L.; Jurczak, W.; Jerkeman, M.; Trotman, J.; Zinzani, P. L.; Belada, D.; Boccomini, C.; Flinn, I. W.; Giri, P.; Goy, A.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors
    Journal Article

    Wang, E.; Mi, X.; Thompson, M. C.; Montoya, S.; Notti, R. Q.; Afaghani, J.; Durham, B. H.; Penson, A.; Witkowski, M. T.; Lu, S. X.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
    Journal Article

    Tilly, H.; Morschhauser, F.; Sehn, L. H.; Friedberg, J. W.; Trnĕný, M.; Sharman, J. P.; Herbaux, C.; Burke, J. M.; Matasar, M.; Rai, S.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Rituximab plus lenalidomide in advanced untreated follicular lymphoma
    Journal Article

    Morschhauser, F.; Fowler, N. H.; Feugier, P.; Bouabdallah, R.; Tilly, H.; Palomba, M. L.; Fruchart, C.; Libby, E. N.; Casasnovas, R.O.; Flinn, I. W.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Phase 3 trial of Ibrutinib plus rituximab in Waldenström's macroglobulinemia
    Journal Article

    Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Orsucci, L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Genetics and pathogenesis of diffuse large B-cell lymphoma
    Journal Article

    Schmitz, R.; Wright, G. W.; Huang, D. W.; Johnson, C. A.; Phelan, J. D.; Wang, J. Q.; Roulland, S.; Kasbekar, M.; Young, R. M.; Shaffer, A. L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma
    Journal Article

    Connors, J. M.; Jurczak, W.; Straus, D. J.; Ansell, S. M.; Kim, W. S.; Gallamini, A.; Younes, A.; Alekseev, S.; Illés, Á.; Picardi, M.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Ibrutinib in previously treated Waldenström's macroglobulinemia
    Journal Article

    Treon, S. P.; Tripsas, C. K.; Meid, K.; Warren, D.; Varma, G.; Green, R. ; Argyropoulos, K. V.; Yang, G.; Cao, Y.; Xu, L.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save